カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Dolutegravir and Dolutegravir Generic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19270）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19270
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：95
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ドルテグラビル＆ドルテグラビルジェネリック医薬品市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のドルテグラビル＆ドルテグラビルジェネリック医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ドルテグラビル＆ドルテグラビルジェネリック医薬品市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・5mg錠、50mg錠

用途別セグメントは次のように区分されます。
・子供、大人

世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場の主要な市場プレーヤーは以下のとおりです。
・ViiV Healthcare Pty Ltd、Emcure Pharmaceuticals、Mylan、Aurobindo Pharma、Qilu Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ドルテグラビル＆ドルテグラビルジェネリック医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なドルテグラビル＆ドルテグラビルジェネリック医薬品メーカーの企業概要、2019年～2022年までのドルテグラビル＆ドルテグラビルジェネリック医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なドルテグラビル＆ドルテグラビルジェネリック医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ドルテグラビル＆ドルテグラビルジェネリック医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのドルテグラビル＆ドルテグラビルジェネリック医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのドルテグラビル＆ドルテグラビルジェネリック医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびドルテグラビル＆ドルテグラビルジェネリック医薬品の産業チェーンを掲載しています。
・第13、14、15章では、ドルテグラビル＆ドルテグラビルジェネリック医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ドルテグラビル＆ドルテグラビルジェネリック医薬品の概要
- 種類別分析（2017年vs2021年vs2028年）：5mg錠、50mg錠
- 用途別分析（2017年vs2021年vs2028年）：子供、大人
- 世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場規模・予測
- 世界のドルテグラビル＆ドルテグラビルジェネリック医薬品生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- ViiV Healthcare Pty Ltd、Emcure Pharmaceuticals、Mylan、Aurobindo Pharma、Qilu Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：5mg錠、50mg錠
・用途別分析2017年-2028年：子供、大人
・ドルテグラビル＆ドルテグラビルジェネリック医薬品の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ドルテグラビル＆ドルテグラビルジェネリック医薬品のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ドルテグラビル＆ドルテグラビルジェネリック医薬品のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ドルテグラビル＆ドルテグラビルジェネリック医薬品の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ドルテグラビル＆ドルテグラビルジェネリック医薬品の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Dolutegravir and Dolutegravir Generic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dolutegravir and Dolutegravir Generic Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Children accounting for % of the Dolutegravir and Dolutegravir Generic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5mg Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dolutegravir and Dolutegravir Generic Drugs include ViiV Healthcare Pty Ltd, Emcure Pharmaceuticals, Mylan, Aurobindo Pharma, and Qilu Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dolutegravir and Dolutegravir Generic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5mg Tablets
50mg Tablets
Market segment by Application can be divided into
Children
Adult
The key market players for global Dolutegravir and Dolutegravir Generic Drugs market are listed below:
ViiV Healthcare Pty Ltd
Emcure Pharmaceuticals
Mylan
Aurobindo Pharma
Qilu Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dolutegravir and Dolutegravir Generic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dolutegravir and Dolutegravir Generic Drugs, with price, sales, revenue and global market share of Dolutegravir and Dolutegravir Generic Drugs from 2019 to 2022.
Chapter 3, the Dolutegravir and Dolutegravir Generic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dolutegravir and Dolutegravir Generic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dolutegravir and Dolutegravir Generic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dolutegravir and Dolutegravir Generic Drugs.
Chapter 13, 14, and 15, to describe Dolutegravir and Dolutegravir Generic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Dolutegravir and Dolutegravir Generic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5mg Tablets
1.2.3 50mg Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Children
1.3.3 Adult
1.4 Global Dolutegravir and Dolutegravir Generic Drugs Market Size & Forecast
1.4.1 Global Dolutegravir and Dolutegravir Generic Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dolutegravir and Dolutegravir Generic Drugs Sales in Volume (2017-2028)
1.4.3 Global Dolutegravir and Dolutegravir Generic Drugs Price (2017-2028)
1.5 Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity Analysis
1.5.1 Global Dolutegravir and Dolutegravir Generic Drugs Total Production Capacity (2017-2028)
1.5.2 Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dolutegravir and Dolutegravir Generic Drugs Market Drivers
1.6.2 Dolutegravir and Dolutegravir Generic Drugs Market Restraints
1.6.3 Dolutegravir and Dolutegravir Generic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 ViiV Healthcare Pty Ltd
2.1.1 ViiV Healthcare Pty Ltd Details
2.1.2 ViiV Healthcare Pty Ltd Major Business
2.1.3 ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Product and Services
2.1.4 ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Emcure Pharmaceuticals
2.2.1 Emcure Pharmaceuticals Details
2.2.2 Emcure Pharmaceuticals Major Business
2.2.3 Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Product and Services
2.2.4 Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Dolutegravir and Dolutegravir Generic Drugs Product and Services
2.3.4 Mylan Dolutegravir and Dolutegravir Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Aurobindo Pharma
2.4.1 Aurobindo Pharma Details
2.4.2 Aurobindo Pharma Major Business
2.4.3 Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Product and Services
2.4.4 Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Qilu Pharmaceutical
2.5.1 Qilu Pharmaceutical Details
2.5.2 Qilu Pharmaceutical Major Business
2.5.3 Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Product and Services
2.5.4 Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dolutegravir and Dolutegravir Generic Drugs Breakdown Data by Manufacturer
3.1 Global Dolutegravir and Dolutegravir Generic Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dolutegravir and Dolutegravir Generic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Dolutegravir and Dolutegravir Generic Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Dolutegravir and Dolutegravir Generic Drugs Manufacturer Market Share in 2021
3.5 Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dolutegravir and Dolutegravir Generic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dolutegravir and Dolutegravir Generic Drugs Market Size by Region
4.1.1 Global Dolutegravir and Dolutegravir Generic Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Region (2017-2028)
4.2 North America Dolutegravir and Dolutegravir Generic Drugs Revenue (2017-2028)
4.3 Europe Dolutegravir and Dolutegravir Generic Drugs Revenue (2017-2028)
4.4 Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Revenue (2017-2028)
4.5 South America Dolutegravir and Dolutegravir Generic Drugs Revenue (2017-2028)
4.6 Middle East and Africa Dolutegravir and Dolutegravir Generic Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dolutegravir and Dolutegravir Generic Drugs Sales in Volume by Type (2017-2028)
5.2 Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Type (2017-2028)
5.3 Global Dolutegravir and Dolutegravir Generic Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dolutegravir and Dolutegravir Generic Drugs Sales in Volume by Application (2017-2028)
6.2 Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Application (2017-2028)
6.3 Global Dolutegravir and Dolutegravir Generic Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2028)
7.2 North America Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2028)
7.3 North America Dolutegravir and Dolutegravir Generic Drugs Market Size by Country
7.3.1 North America Dolutegravir and Dolutegravir Generic Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Dolutegravir and Dolutegravir Generic Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2028)
8.2 Europe Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2028)
8.3 Europe Dolutegravir and Dolutegravir Generic Drugs Market Size by Country
8.3.1 Europe Dolutegravir and Dolutegravir Generic Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Dolutegravir and Dolutegravir Generic Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Market Size by Region
9.3.1 Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2028)
10.2 South America Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2028)
10.3 South America Dolutegravir and Dolutegravir Generic Drugs Market Size by Country
10.3.1 South America Dolutegravir and Dolutegravir Generic Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Dolutegravir and Dolutegravir Generic Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Market Size by Country
11.3.1 Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dolutegravir and Dolutegravir Generic Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dolutegravir and Dolutegravir Generic Drugs
12.3 Dolutegravir and Dolutegravir Generic Drugs Production Process
12.4 Dolutegravir and Dolutegravir Generic Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dolutegravir and Dolutegravir Generic Drugs Typical Distributors
13.3 Dolutegravir and Dolutegravir Generic Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. ViiV Healthcare Pty Ltd Basic Information, Manufacturing Base and Competitors
Table 4. ViiV Healthcare Pty Ltd Major Business
Table 5. ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Product and Services
Table 6. ViiV Healthcare Pty Ltd Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Emcure Pharmaceuticals Major Business
Table 9. Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Product and Services
Table 10. Emcure Pharmaceuticals Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Dolutegravir and Dolutegravir Generic Drugs Product and Services
Table 14. Mylan Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Pharma Major Business
Table 17. Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Product and Services
Table 18. Aurobindo Pharma Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Qilu Pharmaceutical Major Business
Table 21. Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Product and Services
Table 22. Qilu Pharmaceutical Dolutegravir and Dolutegravir Generic Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Dolutegravir and Dolutegravir Generic Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Dolutegravir and Dolutegravir Generic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Dolutegravir and Dolutegravir Generic Drugs Production Site of Key Manufacturer
Table 28. Dolutegravir and Dolutegravir Generic Drugs New Entrant and Capacity Expansion Plans
Table 29. Dolutegravir and Dolutegravir Generic Drugs Mergers & Acquisitions in the Past Five Years
Table 30. Global Dolutegravir and Dolutegravir Generic Drugs Sales by Region (2017-2022) & (K Units)
Table 31. Global Dolutegravir and Dolutegravir Generic Drugs Sales by Region (2023-2028) & (K Units)
Table 32. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 35. Global Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 36. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Dolutegravir and Dolutegravir Generic Drugs Price by Type (2017-2022) & (US$/Unit)
Table 39. Global Dolutegravir and Dolutegravir Generic Drugs Price by Type (2023-2028) & (US$/Unit)
Table 40. Global Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Global Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 42. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Dolutegravir and Dolutegravir Generic Drugs Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Dolutegravir and Dolutegravir Generic Drugs Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Dolutegravir and Dolutegravir Generic Drugs Price by Application (2023-2028) & (US$/Unit)
Table 46. North America Dolutegravir and Dolutegravir Generic Drugs Sales by Country (2017-2022) & (K Units)
Table 47. North America Dolutegravir and Dolutegravir Generic Drugs Sales by Country (2023-2028) & (K Units)
Table 48. North America Dolutegravir and Dolutegravir Generic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Dolutegravir and Dolutegravir Generic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 51. North America Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 52. North America Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 53. North America Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 54. Europe Dolutegravir and Dolutegravir Generic Drugs Sales by Country (2017-2022) & (K Units)
Table 55. Europe Dolutegravir and Dolutegravir Generic Drugs Sales by Country (2023-2028) & (K Units)
Table 56. Europe Dolutegravir and Dolutegravir Generic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Dolutegravir and Dolutegravir Generic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 59. Europe Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 60. Europe Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 61. Europe Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 70. South America Dolutegravir and Dolutegravir Generic Drugs Sales by Country (2017-2022) & (K Units)
Table 71. South America Dolutegravir and Dolutegravir Generic Drugs Sales by Country (2023-2028) & (K Units)
Table 72. South America Dolutegravir and Dolutegravir Generic Drugs Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Dolutegravir and Dolutegravir Generic Drugs Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 75. South America Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 76. South America Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 77. South America Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Dolutegravir and Dolutegravir Generic Drugs Raw Material
Table 87. Key Manufacturers of Dolutegravir and Dolutegravir Generic Drugs Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Dolutegravir and Dolutegravir Generic Drugs Typical Distributors
Table 91. Dolutegravir and Dolutegravir Generic Drugs Typical Customers
List of Figures
Figure 1. Dolutegravir and Dolutegravir Generic Drugs Picture
Figure 2. Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Type in 2021
Figure 3. 5mg Tablets
Figure 4. 50mg Tablets
Figure 5. Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Application in 2021
Figure 6. Children
Figure 7. Adult
Figure 8. Global Dolutegravir and Dolutegravir Generic Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Dolutegravir and Dolutegravir Generic Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Dolutegravir and Dolutegravir Generic Drugs Sales (2017-2028) & (K Units)
Figure 11. Global Dolutegravir and Dolutegravir Generic Drugs Price (2017-2028) & (US$/Unit)
Figure 12. Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity (2017-2028) & (K Units)
Figure 13. Global Dolutegravir and Dolutegravir Generic Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Dolutegravir and Dolutegravir Generic Drugs Market Drivers
Figure 15. Dolutegravir and Dolutegravir Generic Drugs Market Restraints
Figure 16. Dolutegravir and Dolutegravir Generic Drugs Market Trends
Figure 17. Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Manufacturer in 2021
Figure 18. Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Manufacturer in 2021
Figure 19. Dolutegravir and Dolutegravir Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Dolutegravir and Dolutegravir Generic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Dolutegravir and Dolutegravir Generic Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Region (2017-2028)
Figure 23. Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Region (2017-2028)
Figure 24. North America Dolutegravir and Dolutegravir Generic Drugs Revenue (2017-2028) & (USD Million)
Figure 25. Europe Dolutegravir and Dolutegravir Generic Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Revenue (2017-2028) & (USD Million)
Figure 27. South America Dolutegravir and Dolutegravir Generic Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Dolutegravir and Dolutegravir Generic Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Application (2017-2028)
Figure 34. Global Dolutegravir and Dolutegravir Generic Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Country (2017-2028)
Figure 38. North America Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Country (2017-2028)
Figure 39. United States Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Country (2017-2028)
Figure 45. Europe Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Country (2017-2028)
Figure 46. Germany Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Region (2017-2028)
Figure 55. China Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Type (2017-2028)
Figure 62. South America Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Application (2017-2028)
Figure 63. South America Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Country (2017-2028)
Figure 64. South America Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Dolutegravir and Dolutegravir Generic Drugs Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Dolutegravir and Dolutegravir Generic Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Dolutegravir and Dolutegravir Generic Drugs in 2021
Figure 76. Manufacturing Process Analysis of Dolutegravir and Dolutegravir Generic Drugs
Figure 77. Dolutegravir and Dolutegravir Generic Drugs Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の腫瘍用ジェネリック注射剤市場2022年：市場規模予測（～2028年）
  • ジェネリック医薬品中間体CDMOサービスのグローバル市場展望 2023年-2029年：中間体プロセス最適化、中間体製造
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19270 )"世界のドルテグラビル＆ドルテグラビルジェネリック医薬品市場2022年：市場規模予測（～2028年）" (英文：Global Dolutegravir and Dolutegravir Generic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。